LinkedInFacebookXYouTube

RACT

May 2016

Data from Global RACT Analysis Reveals Subjectivity

By |2020-09-23T09:43:22+02:00May 11, 2016|Blog|0 Comments

What are the most common risks in clinical trials? What challenges faces TransCelerate RACT? Read the answers in the latest article published on ACT. by Moe Alsumidaie, Beat Widler, PhD, Peter Schiemann, PhD, Artem Andrianov, PhD Do you want to know about @RACT more and start [...]

Read More
Feb 2016

6 New Features of @RACT 2.0

By |2020-09-23T11:04:33+02:00February 5, 2016|News, RBQM Product Updates|0 Comments

The free @RACT platform, which is used already by many companies, e.g., the first 50 users from big-pharma and CRO (e.g. Daiichi Sankyo, Merz, PPD, MedPace, INC Research etc.), was today updated with the new version 2.0. Besides hundreds of smaller improvements, there are 6 [...]

Read More
Go to Top